Impaired histatin-5 levels and salivary antimicrobial activity against C. Albicans in HIV infected individuals

Journal of AIDS and Clinical Research

Volumn 4, Issue 2, 2013, Pages

  Khan, Shariq A ^a   Fidel Jr, Paul L ^b   Al Thunayyan, Awdah ^a   Varlotta, Sharon ^a   Meiller, Timothy F ^a,d   Jabra Rizk, Mary Ann ^a,c  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

Author keywords

C. Albicans; Histatin 5; HIV AIDS; Innate immunity; Opportunistic infections; Oral candidiasis; Salivary antimicrobial peptide

Indexed keywords

EID: 84879821780     PISSN: None     EISSN: 21556113     Source Type: Journal    
DOI: 10.4172/2155-6113.1000193     Document Type: Article

References (37)

1. Fidel PL Jr (2006) Candida-host interactions in HIV disease: relationships in oropharyngeal candidiasis. Adv Dent Res 19: 80-84.
2. Klein RS, Harris CA, Small CB, Moll B, Lesser M, et al. (1984) Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 311: 354-358.
3. de Repentigny L, Lewandowski D, Jolicoeur P (2004) Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. Clin Microbiol Rev 17: 729-759, table of contents.
4. ndEdn.), ASM Press, Washington DC, USA.
5. Pfaller MA, Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20: 133-163.
6. Lin AL, Johnson DA, Stephan KT, Yeh CK (2003) Alteration in salivary function in early HIV infection. J Dent Res 82: 719-724.
7. Iorgulescu G (2009) Saliva between normal and pathological. Important factors in determining systemic and oral health. J Med Life 2: 303-307.
8. Tiwari M (2011) Science behind human saliva. J Nat Sci Biol Med 2: 53-58.
9. Auvynet C, Rosenstein Y (2009) Multifunctional host defense peptides: antimicrobial peptides, the small yet big players in innate and adaptive immunity. FEBS J 276: 6497-6508.
10. Steinstraesser L, Kraneburg U, Jacobsen F, Al-Benna S (2011) Host defense peptides and their antimicrobial-immunomodulatory duality. Immunobiology 216: 322-333.
11. Zhang L, Falla TJ (2010) Potential therapeutic application of host defense peptides. Methods Mol Biol 618: 303-327.
12. Peters BM, Shirtliff ME, Jabra-Rizk MA (2010) Antimicrobial peptides: primeval molecules or future drugs? PLoS Pathog 6: e1001067.
13. Ahmad M, Piludu M, Oppenheim FG, Helmerhorst EJ, Hand AR (2004) Immunocytochemical localization of histatins in human salivary glands. J Histochem Cytochem 52: 361-370.
14. Edgerton M, Koshlukova SE, Lo TE, Chrzan BG, Straubinger RM, et al. (1998) Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans. J Biol Chem 273: 20438-20447.
15. Flora B, Gusman H, Helmerhorst EJ, Troxler RF, Oppenheim FG (2001) A new method for the isolation of histatins 1, 3, and 5 from parotid secretion using zinc precipitation. Protein Expr Purif 23: 198-206.
16. Oppenheim FG, Xu T, McMillian FM, Levitz SM, Diamond RD, et al. (1988) Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungistatic effects on Candida albicans. J Biol Chem 263: 7472-7477.
17. Nikawa H, Jin C, Fukushima H, Makihira S, Hamada T (2001) Antifungal activity of histatin-5 against non-albicans Candida species. Oral Microbiol Immunol 16: 250-252.
18. Tsai H, Bobek LA (1997) Studies of the mechanism of human salivary histatin-5 candidacidal activity with histatin-5 variants and azole-sensitive and-resistant Candida species. Antimicrob Agents Chemother 41: 2224-2228.
19. Dong J, Vylkova S, Li XS, Edgerton M (2003) Calcium blocks fungicidal activity of human salivary histatin 5 through disruption of binding with Candida albicans. J Dent Res 82: 748-752.
20. Jang WS, Li XS, Sun JN, Edgerton M (2008) The P-113 fragment of histatin 5 requires a specific peptide sequence for intracellular translocation in Candida albicans, which is independent of cell wall binding. Antimicrob Agents Chemother 52: 497-504.
21. Helmerhorst EJ, Troxler RF, Oppenheim FG (2001) The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species. Proc Natl Acad Sci U S A 98: 14637-14642.
22. Gyurko C, Lendenmann U, Helmerhorst EJ, Troxler RF, Oppenheim FG (2001) Killing of Candida albicans by histatin 5: cellular uptake and energy requirement. Antonie Van Leeuwenhoek 79: 297-309.
23. Koshlukova SE, Lloyd TL, Araujo MW, Edgerton M (1999) Salivary histatin 5 induces non-lytic release of ATP from Candida albicans leading to cell death. J Biol Chem 274: 18872-18879.
24. Mochon AB, Liu H (2008) The antimicrobial peptide histatin-5 causes a spatially restricted disruption on the Candida albicans surface, allowing rapid entry of the peptide into the cytoplasm. PLoS Pathog 4: e1000190.
25. Brown AJ, Odds FC, Gow NA (2007) Infection-related gene expression in Candida albicans. Curr Opin Microbiol 10: 307-313.
26. Meiller TF, Hube B, Schild L, Shirtliff ME, Scheper MA, et al. (2009) A novel immune evasion strategy of candida albicans: proteolytic cleavage of a salivary antimicrobial peptide. PLoS One 4: e5039.
27. Navazesh M, Kumar SK; University of Southern California School of Dentistry (2008) Measuring salivary flow: challenges and opportunities. J Am Dent Assoc 139 Suppl: 35S-40S.
28. Epstein JB, Pearsall NN, Truelove EL (1980) Quantitative relationships between Candida albicans in saliva and the clinical status of human subjects. J Clin Microbiol 12: 475-476.
29. Gillum AM, Tsay EY, Kirsch DR (1984) Isolation of the Candida albicans gene for orotidine-5'-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198: 179-182.
30. Humphrey SP, Williamson RT (2001) A review of saliva: normal composition, flow, and function. J Prosthet Dent 85: 162-169.
31. Torres SR, Garzino-Demo A, Meiller TF, Meeks V, Jabra-Rizk MA (2009) Salivary histatin-5 and oral fungal colonisation in HIV+ individuals. Mycoses 52: 11-15.
32. Challacombe SJ, Naglik JR (2006) The effects of HIV infection on oral mucosal immunity. Adv Dent Res 19: 29-35.
33. Lal K, Pollock JJ, Santarpia RP 3rd, Heller HM, Kaufman HW, et al. (1992) Pilot study comparing the salivary cationic protein concentrations in healthy adults and AIDS patients: correlation with antifungal activity. J Acquir Immune Defic Syndr 5: 904-914.
34. Lin AL, Johnson DA, Patterson TF, Wu Y, Lu DL, et al. (2001) Salivary anticandidal activity and saliva composition in an HIV-infected cohort. Oral Microbiol Immunol 16: 270-278.
35. Peters BM, Zhu J, Fidel PL Jr, Scheper MA, Hackett W, et al. (2010) Protection of the oral mucosa by salivary histatin-5 against Candida albicans in an ex vivo murine model of oral infection. FEMS Yeast Res 10: 597-604.
36. Johnson DA, Yeh CK, Dodds MW (2000) Effect of donor age on the concentrations of histatins in human parotid and submandibular/sublingual saliva. Arch Oral Biol 45: 731-740.
37. Sun X, Salih E, Oppenheim FG, Helmerhorst EJ (2009) Kinetics of histatin proteolysis in whole saliva and the effect on bioactive domains with metal-binding, antifungal, and wound-healing properties. FASEB J 23: 2691-2701.